These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor. Tomobe M, Shimazui T, Uchida K, Hinotsu S, Akaza H. J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741 [Abstract] [Full Text] [Related]
3. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors. Helpap B, Loesevitz L, Bulatko A. Virchows Arch; 1994 Jul; 425(3):265-9. PubMed ID: 7812512 [Abstract] [Full Text] [Related]
6. AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern. Hansen AB, Bjerregaard B, Ovesen H, Horn T. Histopathology; 1992 Mar; 20(3):257-62. PubMed ID: 1563712 [Abstract] [Full Text] [Related]
7. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa. Johnson GC, Miller MA, Ramos-Vara JA. J Vet Diagn Invest; 1995 Jan; 7(1):127-36. PubMed ID: 7779947 [Abstract] [Full Text] [Related]
8. AgNORs in benign, borderline and transitional cell neoplasms of the urinary bladder. Misra V, Mukherjee J, Gupta SC, Tandon S, Gupta AK. APMIS; 1998 Oct; 106(10):987-92. PubMed ID: 9833702 [Abstract] [Full Text] [Related]
9. Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer. Lipponen PK, Eskelinen MJ, Nordling S. Br J Cancer; 1991 Dec; 64(6):1139-44. PubMed ID: 1764378 [Abstract] [Full Text] [Related]
14. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters. Skopelitou A, Korkolopoulou P, Papanicolaou A, Christodoulou P, Thomas-Tsagli E, Pavlakis K. Eur Urol; 1992 Jun; 22(3):235-40. PubMed ID: 1361436 [Abstract] [Full Text] [Related]
15. Flow cytometric DNA studies and AgNOR counts in patients with transitional cell carcinoma of the bladder. Celikel C, Dillioğlugil O, Türkeri LN, Başaran M, Yalçiner A, Küllü S, Akdaş A. Eur Urol; 1995 Jun; 28(2):152-7. PubMed ID: 8529742 [Abstract] [Full Text] [Related]
16. Evaluation of nucleolar organizer regions in human bladder cancers by light- and electron-microscopic morphometry. Shimazui T, Uchiyama Y, Uchida K, Hattori K, Takahashi A, Akaza H, Koiso K. Eur Urol; 1998 Jun; 34(5):441-7. PubMed ID: 9803008 [Abstract] [Full Text] [Related]
17. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder. Mansour P, Crocker J, Newman J. Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296 [Abstract] [Full Text] [Related]